Changeflow GovPing Pharma & Drug Safety MHRA Modernises Medicine Information Delivery
Routine Notice Added Final

MHRA Modernises Medicine Information Delivery

Favicon for www.gov.uk MHRA Guidance & Safety
Published March 18th, 2026
Detected March 18th, 2026
Email

Summary

The MHRA has launched a project to modernise how medicines product information is delivered to patients, aiming for greater accessibility and trust. This initiative includes research into the role of patient information leaflets.

What changed

The Medicines and Healthcare products Regulatory Agency (MHRA) has initiated the 'Improving Patient Information' project, which seeks to update the delivery methods for medicines product information. The project's goal is to make this information more accessible, reliable, and prepared for future needs, with a stated commitment to an inclusive approach for all patients.

This initiative is primarily informational at this stage, focusing on modernising delivery rather than imposing new regulatory requirements. Regulated entities, such as drug manufacturers and healthcare providers, should be aware of this strategic direction from the MHRA, which aims to enhance patient understanding and engagement with their medications. No immediate compliance actions or deadlines are specified, but the project signals a future focus on improved patient information standards.

Source document (simplified)

Regulation

Improving Patient Information

MHRA's Improving Patient Information project aims to modernise how medicines product information is delivered, making it more accessible, trusted, and future-ready.

From: Medicines and Healthcare products Regulatory Agency Published 18 March 2026 Get emails about this page

Documents

Improving Patient Information

HTML


Research on the Role of Patient Information Leaflets in Meeting the Information Needs of Patients

PDF, 1.82 MB, 80 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.


Details

Your health decisions matter. The information you receive about your medicines should be clear, accessible, and support informed conversations between you and your healthcare professional. The MHRA is committed to leading a fully inclusive approach to improving medicines information for everyone.

Updates to this page

Published 18 March 2026

Sign up for emails or print this page

Get emails about this page Print this page

Classification

Agency
MHRA
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Healthcare providers Patients
Geographic scope
gb

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Pharmaceuticals Public Health

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when MHRA Guidance & Safety publishes new changes.

Free. Unsubscribe anytime.